tiprankstipranks
Sonim Technologies Inc (SONM)
NASDAQ:SONM
Want to see SONM full AI Analyst Report?

Sonim Technologies (SONM) AI Stock Analysis

372 Followers

Top Page

SONM

Sonim Technologies

(NASDAQ:SONM)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$4.50
▲(20.64% Upside)
Action:Reiterated
Date:06/05/26
The score is weighed down primarily by distressed financial performance (unstable revenue, persistent losses, negative equity, and accelerating cash burn) and negative corporate events (reduced financing flexibility and Nasdaq delisting risk). Technical indicators provide only modest near-term support, while valuation is constrained by unprofitability and no stated dividend yield.
Positive Factors
Rugged enterprise device niche
Sonim’s focus on ruggedized devices for enterprise and industrial users creates a durable niche less susceptible to consumer commoditization. Harsh-environment hardware has higher switching costs, predictable replacement cycles, and steady demand from frontline workforces, supporting long-term product revenue and accessory sales.
Negative Factors
Severe and worsening cash burn
Consistent, large negative operating and free cash flow that materially worsened on a TTM basis signals an unsustainable cash burn. This exhausts liquidity, forces reliance on external financing, and constrains investment in product development and channels—raising medium-term survival and execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Rugged enterprise device niche
Sonim’s focus on ruggedized devices for enterprise and industrial users creates a durable niche less susceptible to consumer commoditization. Harsh-environment hardware has higher switching costs, predictable replacement cycles, and steady demand from frontline workforces, supporting long-term product revenue and accessory sales.
Read all positive factors

Sonim Technologies (SONM) vs. SPDR S&P 500 ETF (SPY)

Sonim Technologies Business Overview & Revenue Model

Company Description
DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim...
How the Company Makes Money
Sonim makes money primarily by selling rugged mobile hardware (such as rugged smartphones and feature phones) through wireless carriers, distributors, and other channel partners to enterprise and industrial customers. Revenue is recognized from pr...

Sonim Technologies Financial Statement Overview

Summary
Financials appear distressed: revenue is highly unstable (including a reported $0 for 2025 annual), losses are persistent and large, equity has turned negative, and operating/free cash flow are deeply negative with worsening TTM burn—indicating elevated liquidity and solvency risk.
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
8
Very Negative
BreakdownMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue0.0058.30M93.63M69.83M54.57M
Gross Profit-4.30M9.92M19.32M11.62M6.41M
EBITDA-2.17M-29.84M2.50M-11.43M-36.33M
Net Income-20.66M-33.65M-90.00K-14.09M-38.63M
Balance Sheet
Total Assets43.90M39.74M56.04M53.69M41.09M
Cash, Cash Equivalents and Short-Term Investments1.30M5.34M9.40M13.21M11.23M
Total Debt5.24M0.0055.00K213.00K214.00K
Total Liabilities50.63M45.44M33.67M33.64M22.46M
Stockholders Equity-6.73M-5.70M22.37M20.05M18.63M
Cash Flow
Free Cash Flow-23.53M-8.70M-4.09M-12.37M-38.52M
Operating Cash Flow-23.53M-8.49M-4.05M-12.36M-38.48M
Investing Cash Flow0.00-214.00K-36.00K-8.00K-46.00K
Financing Cash Flow19.49M4.65M272.00K14.35M27.61M

Sonim Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.73
Price Trends
50DMA
4.20
Positive
100DMA
4.62
Positive
200DMA
6.92
Negative
Market Momentum
MACD
0.10
Negative
RSI
51.96
Neutral
STOCH
45.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SONM, the sentiment is Positive. The current price of 3.73 is below the 20-day moving average (MA) of 4.69, below the 50-day MA of 4.20, and below the 200-day MA of 6.92, indicating a neutral trend. The MACD of 0.10 indicates Negative momentum. The RSI at 51.96 is Neutral, neither overbought nor oversold. The STOCH value of 45.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SONM.

Sonim Technologies Risk Analysis

Sonim Technologies disclosed 56 risk factors in its most recent earnings report. Sonim Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sonim Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$37.57M19.4532.21%867.91%98.63%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
48
Neutral
$26.68M-5.25-13.41%-17.47%-81.59%
44
Neutral
$7.07M-0.411515.04%4.17%-238.36%
41
Neutral
$2.01M-0.01-260.09%-49.61%28.35%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SONM
Sonim Technologies
4.75
-15.41
-76.43%
UTSI
UTStarcom
2.81
0.52
22.44%
FIEE
FiEE
4.41
1.30
41.64%
ASNS
Actelis Networks, Inc.
0.08
-6.93
-98.90%
MOB
Mobilicom
5.89
3.21
119.78%

Sonim Technologies Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Sonim Technologies Ends Major Equity Purchase Agreement
Negative
Jun 4, 2026
DNA X, Inc. previously entered into a ChEF Purchase Agreement with Chardan Capital Markets LLC on September 29, 2025, under which Chardan committed, subject to conditions, to purchase up to $500 million of the company’s common stock and rece...
Delistings and Listing ChangesPrivate Placements and FinancingRegulatory Filings and Compliance
Sonim Technologies Faces Nasdaq Delisting After New Financing
Negative
May 27, 2026
On May 20, 2026, DNA X, Inc. entered into a securities purchase agreement with DNA Holdings Venture, Inc., and on May 26, 2026, it issued a $3.05 million secured convertible note, funded by $1.8 million in cash and the exchange of a prior note plu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 05, 2026